Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
about
COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why.
P2860
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@ast
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@en
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@nl
type
label
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@ast
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@en
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@nl
prefLabel
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@ast
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@en
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@nl
P2093
P2860
P50
P1433
P1476
Tumor suppressors BTG1 and IKZ ...... mphoblastic leukemia patients.
@en
P2093
Blanca Scheijen
Dorette van Ingen Schenau
Edwin Sonneveld
Esmé Waanders
Esther Tijchon
Frank N van Leeuwen
Judith M Boer
Laurens T van der Meer
Liesbeth van Emst
Luciano Dalla-Pozza
P2860
P304
P356
10.3324/HAEMATOL.2016.153023
P577
2016-12-15T00:00:00Z